GL Armstrong, A Wasley, EP Simard, GM … - Annals of Internal Medicine, 2006 - Am Coll Physicians From National Center for Infectious Diseases, Centers for Disease Control and
Prevention, Atlanta, Georgia, and National Center for Health Statistics, Centers
for Disease Control and Prevention, Hyattsville, Maryland. Cited by 347 - Related articles - BL Direct - All 4 versions
- ►elsevierhealth.com HS Conjeevaram, MW Fried, LJ Jeffers, NA … - Gastroenterology, 2006 - Elsevier Background & Aims: Compared with Caucasian Americans (CA), African Americans
(AA) with chronic hepatitis C are less likely to respond to interferon-based
antiviral therapy. Methods: In a multicenter treatment trial, 196 AA and ... Cited by 139 - Related articles - All 6 versions
GL Armstrong, MJ Alter, GM McQuillan, HS … - Hepatology, 2000 - interscience.wiley.com Because chronic liver disease may develop many years after acute hepatitis C
virus (HCV) infection, the past incidence of acute infections is a major
determinant of the future burden of HCV-associated complications. We ... Cited by 317 - Related articles - BL Direct - All 5 versions
- ►shouxi.net AJ Muir, JD Bornstein, PG Killenberg - The New England journal of medicine, 2004 - nejm.highwire.org Methods We treated 100 black patients and 100 non-Hispanic white patients with
chronic hepatitis C with peginterferon alfa-2b and ribavirin for 48 weeks.
Enrollment was controlled so that the two groups had similar proportions of ... Cited by 212 - Related articles - BL Direct - All 7 versions
DB Strader, T Wright, DL Thomas, LB Seeff… - Hepatology, 2004 - texasliver.com These recommendations provide a data-supported approach. They are based on the
following: (1) a formal review and analysis of the recently-published world
literature on the topic [Medline search]; (2) the American College of ... Cited by 1057 - Related articles - View as HTML - All 11 versions
- ►ajph.org [PDF] JB Wong, GM McQuillan, JG McHutchison, T … - American Journal of Public Health, 2000 - Am Public Health Assoc John B. Wong is with the Division of Clinical De- cision Making, Informatics and
Telemedicine, De- partment of Medicine, New England Medical Cen- ter, Tupper
Research Institute, Tufts University School of Medicine, Boston, Mass. ... Cited by 366 - Related articles - BL Direct - All 4 versions
GL Davis, JE Albright, SF Cook, DM … - Hepatology - interscience.wiley.com Chronic hepatitis C virus (HCV) infection is common and often results in slowly
progressive liver disease. Although acute hepatitis C is now uncommon, most
patients with acute infection have developed chronic hepatitis, and, ... Cited by 257 - Related articles - BL Direct - All 6 versions
- ►annals.org MJ Alter, LB Seeff, BR Bacon, DL Thomas, MO … - Annals of internal medicine, 2004 - Am Coll Physicians In the United States, chronic hepatitis C virus (HCV) infection affects an
estimated 3 million persons, most younger than 50 years of age. It is one of the
leading causes of chronic liver disease morbidity and mortality and the ... Cited by 51 - Related articles - BL Direct - All 8 versions
MJ Alter, WL Kuhnert, L Finelli… - Mmwr, 2003 - cdc.gov Testing for the presence of antibody to hepatitis C virus (anti-HCV) is
recommended for initially identifying persons with hepatitis C virus (HCV)
infection (CDC. Recommendations for prevention and control of hepatitis C ... Cited by 155 - Related articles - Cached - All 4 versions
JM Sánchez–Tapias, M Diago, P Escartín, J … - Gastroenterology, 2006 - Elsevier Background & Aims: Patients with chronic hepatitis C who do not respond rapidly
to therapy have a low chance of developing a sustained virologic response (SVR)
when treated for 48 weeks. This study investigated whether treatment for 72 ... Cited by 171 - Related articles - All 7 versions
